H.R. 1381 (119th)Bill Overview

COVID–19 Vaccination Non-Discrimination Act

Health|Cardiovascular and respiratory healthDisability and health-based discrimination
Cosponsors
Support
Republican
Introduced
Feb 14, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for c…

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

The bill bars federal funds from going to any facility that refuses to provide medical treatment to an individual because of that individual's COVID-19 vaccination status. It explicitly applies to funds authorized or appropriated by federal law, including Medicare (Title XVIII), Medicaid (Title XIX), and CHIP (Title XXI).

Why people may split

Progressives emphasize access and anti-discrimination benefits

Watch point

Relative to its intended legislative type, this bill articulates a clear, narrow policy goal (prohibiting federal funds to facilities that refuse treatment based on COVID-19 vaccination status) but is sparsely constructed: it lacks key definitions, implementation mechanisms, fiscal analysis, integration details with existing statutory frameworks, edge-case handling, and accountability provisions.

The bill bars federal funds from going to any facility that refuses to provide medical treatment to an individual because of that individual's COVID-19 vaccination status.

It explicitly applies to funds authorized or appropriated by federal law, including Medicare (Title XVIII), Medicaid (Title XIX), and CHIP (Title XXI).

Passage40/100

Low fiscal impact helps, but ideological sensitivity, absence of compromise features, and implementation ambiguities reduce prospects.

CredibilityMisaligned

Relative to its intended legislative type, this bill articulates a clear, narrow policy goal (prohibiting federal funds to facilities that refuse treatment based on COVID-19 vaccination status) but is sparsely constructed: it lacks key definitions, implementation mechanisms, fiscal analysis, integration details with existing statutory frameworks, edge-case handling, and accountability provisions.

Contention65/100

Progressives emphasize access and anti-discrimination benefits

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Federal agenciesFederal agencies

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Potential benefitPreserves patient access to medical treatment regardless of COVID‑19 vaccination status.
  • Potential benefitProtects enrollment populations served by Medicare, Medicaid, and CHIP from treatment denial.
  • Federal agenciesEstablishes a federal expectation of nondiscrimination tied to federal health program funding.
Likely burdened
  • Potential burdenCould conflict with facility infection‑control policies and staff vaccination requirements.
  • Federal agenciesMay force facilities to choose between federal funding and maintaining strict infection‑prevention practices.
  • Potential burdenWould likely increase administrative and compliance costs for providers and payors.
03 · Why people split

Why the argument around this bill splits.

Progressives emphasize access and anti-discrimination benefits
Progressive90%

Likely supportive because it prevents discrimination in access to care and uses federal funding leverage to protect patients.

Would welcome the straightforward prohibition but seek stronger enforcement and clarity on definitions and remedies.

Leans supportive
Centrist70%

Generally favorable to preventing denials of care, but cautious about vagueness and unintended consequences.

Would want narrow exceptions for legitimate medical or infection-control reasons and implementation guidance.

Leans supportive
Conservative30%

Skeptical because it conditions federal funding on operational decisions, potentially overriding religious liberty and institutional autonomy.

Likely to press for exemptions for faith-based hospitals and medical-judgment discretion.

Likely resistant
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood40/100

Low fiscal impact helps, but ideological sensitivity, absence of compromise features, and implementation ambiguities reduce prospects.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • No definitions of 'facility' or 'treatment' provided
  • No enforcement mechanism or penalty procedures specified
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Progressives emphasize access and anti-discrimination benefits

Low fiscal impact helps, but ideological sensitivity, absence of compromise features, and implementation ambiguities reduce prospects.

Unlocked analysis

Relative to its intended legislative type, this bill articulates a clear, narrow policy goal (prohibiting federal funds to facilities that refuse treatment based on COVID-19 vaccination status) but is sparsely construct…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis